Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Each vial contains water for injection preserved with 0.9% benzyl alcohol under strict sterile manufacturing conditions
Advancements in peptide synthesis have also influenced the research landscape
The MHRA has disrupted two UK manufacturing facilities producing counterfeit retatrutide and tirzepatide pens, in October 2025 and February 2026
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, directly addresses this metabolic block by improving insulin sensitivity and reducing appetitecreating conditions for meaningful weight loss and hormonal improvement
These include: Starting weight People with a higher initial body weight often experience more significant weight loss initially
Human gain-of-function MC4R variants show signaling bias and protect against obesity
US$ 20.19
US$ 28.95
US$ 25.52
